Related Experiment Videos
[Studies on tobramycin by the intravenous drip infusion method]
The Japanese Journal of Antibiotics
|April 1, 1984
Summary
Intravenous drip infusion of tobramycin (TOB) showed high efficacy in treating urinary tract infections. This aminoglycoside antibiotic demonstrated a 75% clinical efficacy rate and an 80% bacterial disappearance rate with minimal side effects.
Area of Science:
- Pharmacology
- Microbiology
- Clinical Medicine
Context:
- Aminoglycoside antibiotics are crucial for treating bacterial infections.
- Tobramycin (TOB) has recently been approved for intravenous administration.
- Evaluating new drug delivery methods is essential for optimizing therapeutic outcomes.
Purpose:
- To assess the fundamental and clinical efficacy of tobramycin administered via intravenous drip infusion.
- To determine the pharmacokinetic profile of tobramycin in healthy volunteers.
- To evaluate the clinical effectiveness and safety of tobramycin in patients with complicated urinary tract infections.
Summary:
- Pharmacokinetic studies in healthy volunteers showed predictable tobramycin levels in blood and urine following 60 mg/1 hr and 120 mg/2 hr infusions.
- Assay methods (bioassay and EMIT) demonstrated high correlation, validating measurement techniques.
- Clinical evaluation in 12 patients with chronic complicated urinary tract infections revealed a 75% efficacy rate and 80% bacterial eradication, with only one case of mild S-GOT elevation.
Impact:
- Intravenous drip infusion of tobramycin is an effective and safe therapeutic option for complicated urinary tract infections.
- The study provides valuable data for optimizing tobramycin dosing and administration protocols.
- This research contributes to the understanding of aminoglycoside antibiotic efficacy in clinical settings.